Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kimberly, Amoroso"'
Autor:
David B. Solit, Angela G. Arnold, Mark E. Robson, Diana Mandelker, Michael F. Berger, Shweta S. Chavan, Maksym Misyura, Michael Walsh, Anna Maio, Sarah R. Kane, Karen Cadoo, Yelena Kemel, Preethi Srinivasan, Ying Liu, Jinru Shia, Kenneth Offit, Kelsey Breen, Jennifer Kennedy, Margaret Sheehan, Semanti Mukherjee, Caitlin Bourque, Chaitanya Bandlamudi, Zalak Patel, Maria I. Carlo, Zsofia K. Stadler, Amanda Catchings, Erin E. Salo-Mullen, Arnold J. Markowitz, Barry S. Taylor, Prince Rainier Tejada, Rosalba Sacca, Vanessa Marcell, Alicia Latham, Ozge Ceyhan-Birsoy, Mark T.A. Donoghue, Kimberly Amoroso, Megha Ranganathan
Publikováno v:
JCO Precision Oncology. :455-465
PURPOSE NTHL1 and MSH3 have been implicated as autosomal recessive cancer predisposition genes. Although individuals with biallelic NTHL1 and MSH3 pathogenic variants (PVs) have increased cancer and polyposis risk, risks for monoallelic carriers are
Autor:
Erin E, Salo-Mullen, Anna, Maio, Semanti, Mukherjee, Chaitanya, Bandlamudi, Jinru, Shia, Yelena, Kemel, Karen A, Cadoo, Ying, Liu, Maria, Carlo, Megha, Ranganathan, Sarah, Kane, Preethi, Srinivasan, Shweta S, Chavan, Mark T A, Donoghue, Caitlin, Bourque, Margaret, Sheehan, Prince Rainier, Tejada, Zalak, Patel, Angela G, Arnold, Jennifer A, Kennedy, Kimberly, Amoroso, Kelsey, Breen, Amanda, Catchings, Rosalba, Sacca, Vanessa, Marcell, Arnold J, Markowitz, Alicia, Latham, Michael, Walsh, Maksym, Misyura, Ozge, Ceyhan-Birsoy, David B, Solit, Michael F, Berger, Mark E, Robson, Barry S, Taylor, Kenneth, Offit, Diana, Mandelker, Zsofia K, Stadler
Publikováno v:
JCO Precis Oncol
NTHL1 and MSH3 have been implicated as autosomal recessive cancer predisposition genes. Although individuals with biallelic NTHL1 and MSH3 pathogenic variants (PVs) have increased cancer and polyposis risk, risks for monoallelic carriers are uncertai
Autor:
Sherry R. Boyar, Megan Harlan Fleischut, Kenneth Offit, Angela G. Arnold, Mark E. Robson, Beth Siegel, Melissa Salerno, Margaret Sheehan, Jennifer L. Hay, Margaux Genoff, Jada G. Hamilton, Kimberly Amoroso, Erin E. Salo-Mullen
Publikováno v:
Breast Cancer Research and Treatment. 162:297-306
Women who are newly diagnosed with breast cancer may consider contralateral prophylactic mastectomy (CPM) to reduce their future risk of cancer in their unaffected breast. Pre-surgical BRCA1/2 genetic testing can provide valuable risk information to
Autor:
Rosalba Sacca, Zsofia K. Stadler, Jennifer Kennedy, Alicia Latham, Kimberly Amoroso, Liying Zhang, Maria I. Carlo, Michael Walsh, Ozge Birsoy, Kenneth Offit, Temima Wildman, Diana Mandelker, Mark E. Robson, Yelena Kemel, Karen Cadoo, Zoe Steinsnyder
Publikováno v:
JCO Precision Oncology
Autor:
Janice L. Berliner, Angela G. Arnold, Magan Trottier, Jennifer L. Hay, Kenneth Offit, Erin E. Salo-Mullen, Zsofia K. Stadler, M.E. Robson, N Sekhri, Noah D. Kauff, P Gaissert, M Harlan Fleischut, Vanessa Marcell, Kimberly Amoroso, Michael Walsh, Beth Siegel, Jada G. Hamilton, Margaret Sheehan
Publikováno v:
Cancer Research. 76:P2-09
Background: Multiplex genetic testing involves the simultaneous analysis of a panel of known cancer susceptibility genes. Although efficient and cost-effective, multiplex testing presents several challenges for patients and clinicians: these tests pr
Publikováno v:
Breast cancer research and treatment. 168(2)
PURPOSE: Germline mutations in BRCA1 and BRCA2 confer a significant increase in risk for cancer, and determining pathogenicity of a BRCA variant can guide the clinical management of the disease. About 1/3 of BRCA1 variants reported in the public data
Autor:
Jada G. Hamilton, Kenneth Offit, Beth Siegel, M Harlan Fleischut, M Salerno, Emily Glogowski, Erin E. Salo-Mullen, Kimberly Amoroso, Jennifer L. Hay, M.E. Robson, Angela G. Arnold, Margaret Sheehan
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 24:760-760
Pre-surgical BRCA1/2 genetic testing provides valuable risk information to guide a newly-diagnosed breast cancer patient's decision about whether to have a contralateral prophylactic mastectomy (CPM) to reduce her future risk of cancer in her unaffec
Autor:
Kimberly, Amoroso
Publikováno v:
Newsletter on philosophy and medicine. 5(1)